Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, Feb 2026, Mar 2026 and Apr 2026.
- Largest single sale: $381K (9,400 shares) of Maze Therapeutics, Inc. on Dec 29, 2025. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Jan 30, 2025 | Apr 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Apr 1, 2026, Maze Therapeutics, Inc.: sold 2,500 shares for $74K, under a disclosed plan; 2,500 shares acquired by exercising options. 1 filing: 1
- Mar 2, 2026, Maze Therapeutics, Inc.: sold 5,000 shares for $226K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Feb 2, 2026, Maze Therapeutics, Inc.: sold 5,000 shares for $230K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Jan 22, 2026, Maze Therapeutics, Inc.: sold 5,000 shares for $228K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Jan 2, 2026, Maze Therapeutics, Inc.: sold 5,000 shares for $196K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.